Highly sensitive bioassay of lidocaine in human plasma by high-performance liquid chromatography-tandem mass spectrometry

被引:45
作者
Dal Bo, L [1 ]
Mazzucchelli, P [1 ]
Marzo, A [1 ]
机构
[1] IPAS SA, CH-6853 Ligornetto, Switzerland
关键词
lidocaine; bupivacaine; anaesthetics;
D O I
10.1016/S0021-9673(99)00415-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A very sensitive HPLC-tandem mass spectrometric (LC-MS-MS) method for assaying lidocaine in human plasma was set up and fully validated. Lidocaine and an internal standard (bupivacaine) were extracted from 1 ml of alkalinized plasma with tert.-butylmethyl ether, back-extracted to a H3PO4 acidified solution and injected into a C-18 column. Acetonitrile-26 mmol/l ammonium acetate, pH 4.5 (70:30, v/v) was the mobile phase at a flow-rate of 1 ml/min. The effluent was detected by PE Sciex API 365 LC-MS-MS system in positive ion mode. Ionisation was performed using an atmospheric pressure chemical ionization ion source operating at 400 degrees C. The multi reaction monitoring transition 235-->86 was monitored. Linearity was ascertained in the 0.2-30 ng/ml range with a limit of quantitation of 0.2 ng/ml. Intra- and inter-assay precision and accuracy were less than or equal to 3.8%. The high sensitivity and specificity achieved by the method allowed concentrations of lidocaine to be measured in plasma of healthy subjects topically treated with lidocaine (5% ointment) on normal skin over a 32-h period after dosing. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 9 条
[1]  
JUHLIN L, 1989, ACTA DERM-VENEREOL, V69, P18
[2]  
JUHLIN L, 1980, ACTA DERM-VENEREOL, V60, P544, DOI 10.2340/0001555560544546
[3]   BIOAVAILABILITY DETERMINATION OF LIDOCAINE BY CAPILLARY GAS-CHROMATOGRAPHY AMMONIA CHEMICAL IONIZATION MASS-SPECTROMETRY [J].
KARLAGANIS, G ;
BIRCHER, J .
BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1987, 14 (09) :513-516
[4]   SIMULTANEOUS DETERMINATION OF LIDOCAINE, PRILOCAINE AND THE PRILOCAINE METABOLITE O-TOLUIDINE IN PLASMA BY HIGHPERFORMANCE LIQUID-CHROMATOGRAPHY [J].
KLEIN, J ;
FERNANDES, D ;
GAZARIAN, M ;
KENT, G ;
KOREN, G .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 655 (01) :83-88
[5]  
LOFTI H, 1997, THER DRUG MONIT, V19, P160
[6]  
ONeal CL, 1996, CLIN CHEM, V42, P330
[7]   An improved method for the measurement of lidocaine and its metabolites in rat plasma [J].
Rossi, SS ;
Moore, AC ;
Hagey, LR ;
Yaksh, TL ;
Chaplan, SR .
THERAPEUTIC DRUG MONITORING, 1997, 19 (02) :179-184
[8]   ANALYTICAL METHODS VALIDATION - BIOAVAILABILITY, BIOEQUIVALENCE, AND PHARMACOKINETIC STUDIES [J].
SHAH, VP ;
MIDHA, KK ;
DIGHE, S ;
MCGILVERAY, IJ ;
SKELLY, JP ;
YACOBI, A ;
LAYLOFF, T ;
VISWANATHAN, CT ;
COOK, CE ;
MCDOWALL, RD ;
PITTMAN, KA ;
SPECTOR, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (03) :309-312
[9]   SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY USING 9-FLUORENYLMETHYLCHLOROFORMATE FOR MONITORING CONTROLLED-RELEASE LIDOCAINE IN PLASMA [J].
SINTOV, A ;
SIDEN, R ;
LEVY, RJ .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 496 (02) :335-344